CN109762792A - A kind of porcine reproductive and respiratory syndrome virus is fitted into strain and its application - Google Patents

A kind of porcine reproductive and respiratory syndrome virus is fitted into strain and its application Download PDF

Info

Publication number
CN109762792A
CN109762792A CN201910046125.0A CN201910046125A CN109762792A CN 109762792 A CN109762792 A CN 109762792A CN 201910046125 A CN201910046125 A CN 201910046125A CN 109762792 A CN109762792 A CN 109762792A
Authority
CN
China
Prior art keywords
strain
respiratory syndrome
porcine reproductive
virus
rtd111
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910046125.0A
Other languages
Chinese (zh)
Other versions
CN109762792B (en
Inventor
姜平
张乔亚
张日腾
白娟
姜辰龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Agricultural University
Original Assignee
Nanjing Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Agricultural University filed Critical Nanjing Agricultural University
Priority to CN201910046125.0A priority Critical patent/CN109762792B/en
Publication of CN109762792A publication Critical patent/CN109762792A/en
Application granted granted Critical
Publication of CN109762792B publication Critical patent/CN109762792B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a kind of porcine reproductive and respiratory syndrome virus to be fitted into strain and its application, the present invention is based on the full-length infectious CDNA clones of highly pathogenic PRRSV TJM-F92 vaccine low virulent strain and class NADC30 hypotype strain FJ1402, using Reverse Genetics, building has obtained porcine reproductive and respiratory syndrome virus and has been fitted into strain.The chimeric strain experiment proves that; viral growth speed and virus titer are lower than its original strain TJM-F92 on Marc-145 cell; virulence is low; there is preferable immanoprotection action to HP-PRRSV strain BB0907 and class NADC30 strain FJ1402; effective Cross immunogenicity can be provided to highly pathogenic strain and class NADC30 virus strain infection, important foundation has been established in the development for the disease New-type wide-spectrum vaccine.

Description

A kind of porcine reproductive and respiratory syndrome virus is fitted into strain and its application
Technical field
The present invention relates to a kind of new porcine reproductive and respiratory syndrome virus to be fitted into strain, further relates to the chimeric strain strain Construction method and the application in the candidate vaccine of preparation prevention porcine reproductive and respiratory syndrome prevalence strain.
Background technique
Porcine reproductive and respiratory syndrome (porcine reproductive and respiratory syndrome, It PRRS is) by porcine reproductive and respiratory syndrome virus (porcine reproductive and respiratory syndrome Virus, PRRSV) caused by a kind of viral blight for seriously endangering pig breeding industry, the complicated multiplicity of clinical symptoms, feature is mother The respiratory disease of pig breeding dysfunction or each age in days swinery.The virus in 1996 is split into for the first time in China, after gradually spread The whole nation.Summer and autumn in 2006 are even more to break out highly pathogenic PRRSV (HP-PRRSV), and main clinical characteristics are high fever, high-incidence Sick rate and the death rate cause huge economic loss to pig breeding industry.HP-PRRSV strain can cause piglet compared to classics PRRSV More serious clinical symptoms cause higher morbidity and mortality.PRRSV genome is easy to happen variation and recombination, and giving should Sick prevention and control bring bigger difficulty.
In recent years, domestic to be separated to successively and the higher Strain of U.S. PRRSV NADC30 strain homology, referred to as class NADC30 strain.Epidemic status has been presented in China in Molecule Epidemiology Investigation studies have shown that class NADC30 strain.The U.S. NADC30 strain is pathogenic to piglet weaker, but obvious with the class NADC30 strains of pathogenic after HP-PRRSV generation genetic recombination Enhancing.PRRSV is single strand plus RNA virus, belongs to Arteriviridae, Arterivirus.The full length viral genome is about 15kb includes at least 11 open reading frame (ORFs), and wherein ORF1a and ORF1b encodes non-structural protein, the end of genome 3 ' 8 The structural proteins of a ORFs main code virus.The oligomer that wherein GP2, GP3, GP4 and M albumen are formed is to induction neutralizing antibody There is certain effect.There are t cell epitopes for these albumen, can be immune with inducing T cell.GP5 is encoded by ORF5, is virus envelope sugar Albumen, and be the main host protective antigen of PRRSV, include the closely related neutralizing epitope of induction neutralizing antibody, GP5 amino The variation of acid sequence will directly reduce the cross protection rate of PRRS vaccine strain.M albumen is the non-glycosylated film egg encoded by ORF6 It is white, it is capable of absorption and the inducing cellular immune of mediate retroviral.GP5 and M albumen can exist in the form of heterodimer, and this Kind heterodimer can promote GP5 albumen from endoplasmic reticulum to Golgi transport, be induced to further enhance GP5 albumen Immune response.N protein is then a kind of highly conserved nucleocapsid protein, has extremely strong immunogenicity, but its induction is anti- Body does not have the ability for neutralizing virus.Since virus genome RNA mutation, recombination etc. cause strain that variation diversity and something lost is presented Diversified trend is passed, brings severe challenge for PRRS prevention and control.Currently, attenuated vaccine is commercialized to homologous strain gene in PRRSV Preferable immanoprotection action, but it is lower to the cross-protection of special-shaped strain.Currently, the commercialized vaccine of PRRS mainly have it is weak Virus live vaccine and inactivated vaccine, attenuated vaccine is preferable than inactivated vaccine immune efficacy, but to different subtype strain intersecting protective It is poor.Such as clinic caused by HP-PRRSV can be effectively relieved in the attenuated vaccines such as TJM-F92, HuN4-F112, JXA1-R and R98 Symptom reduces the piglet death rate, but limited to class NADC30 strain immanoprotection action, therefore studies New-type wide-spectrum vaccine very It is necessary.
Summary of the invention
In view of the deficiencies of the prior art, the present invention provides a kind of chimeric poison of porcine reproductive and respiratory syndrome virus Strain.The Novel chimeric strain virulence is low, has good immunogenicity, can be to highly pathogenic PRRSV strain and PRRSV class NADC30 virus strain infection provides effective Cross immunogenicity, has established important foundation for the disease new generation vaccine development.
Present invention separation obtains PRRSV class NADC30 strain FJ1402 (abbreviation class NADC30 strain FJ1402) and high cause Characteristic of disease PRRSV strain BB0907 (abbreviation HP-PRRSV BB0907), class NADC30 strain FJ1402 and HP-PRRSV BB0907 Cause a disease similar temperament.
The chimeric strain of PRRSV provided by the invention is the expression on the Nsp2 gene by highly pathogenic PRRSV vaccine strain The genetic fragment of 323-433 amino acids (aa) deletes, simultaneously replaces with its ORF5-6 (open reading frame 5 and 6) The ORF5-6 of PRRSV class NADC30 strain is constructed and is obtained.
The PRRSV vaccine strain that the present invention selects is highly pathogenic PRRSV TJM-F92 vaccine low virulent strain, selection PRRSV class NADC30 strain is class NADC30 strain FJ1402.
The present invention is when building PRRSV is fitted into strain, in the overall length sense of highly pathogenic PRRSV TJM-F92 vaccine low virulent strain On the basis of metachromia cDNA clone and class NADC30 strain FJ1402, using Reverse Genetics, by the Nsp2 gene of TJM-F92 The genetic fragment of 323-433 aa of loss of expression (lacking 111 aa altogether), and Nsp2 gene delection is expressed into 323-433 Position aa after highly pathogenic PRRSV TJM-F92 strain structural protein gene ORF2-7 (ORF2, ORF3, ORF4, ORF5, ORF6 and ORF7) and the region ORF5-6 (ORF5 and ORF6) be substituted for class NADC30 hypotype strain FJ1402 respectively and encode accordingly Region (ORF2-7 and ORF5-6), constructs three infection clones, and the recombinant plasmid containing these three infection clones is distinguished Mare-145 cell is transfected, rescue obtains three and recombinates chimeric strain, is named as rTd111 (TJM-F92 strain Nsp2 missing 111 aa), rTd111/F2-7 (rTd111 strain ORF2-7 is replaced into FJ1402 strain ORF2-7) and rTd111/F5-6 (rTd111 strain ORF5-6 is replaced into FJ1402 strain ORF5-6).
PRRSV of the present invention is fitted into the Constructed wetlands of strain specifically:
(1) infectious CDNA clones for constructing highly pathogenic PRRSV TJM-F92 vaccine low virulent strain, are named as pCMV- TJM;
(2) segment that 323-433 aa (totally 111 aa) are expressed on the Nsp2 gene of pCMV-TJM is deleted, building Infectious CDNA clones are obtained, pTd111 is named as;
(3) using pTd111 as skeleton, its ORF2-7 and ORF5-6 is replaced with into porcine reproductive and respiratory syndrome class respectively The ORF2-7 and ORF5-6 of NADC30 strain FJ1402, building obtain infectious CDNA clones, be named as pTd111/F2-7, pTd111/F5-6;
(4) pTd111, pTd111/F2-7, pTd111/F5-6 are subjected to virus rescue respectively, obtain three kinds of chimeric strains, It is named as rTd111, rTd111/F2-7 and rTd111/F5-6.
RTd111, rTd111/F2-7 and rTd111/F5-6 are passed on respectively 5 times, gene inheritance is stable.Further To rTd111, rTd111/F2-7 and rTd111/F5-6 be fitted into strain carry out verification experimental verification, as the result is shown: rTd111/F2-7 and RTd111/F5-6 is fitted into the speed of growth and virus titer of the strain on Marc-145 cell and is slightly below its original TJM-F92 poison Strain, but the speed of growth on PAM cell and virus titer are similar to original TJM-F92 strain.After infecting PAMs cell, The proinflammatory cytokines of rTd111/F5-6 induction are similar to Td111, slightly above TJM-F92, but rTd111/F2-7 is induced Proinflammatory cytokines be apparently higher than Td111, rTd111/F5-6 and TJM-F92.By rTd111, rTd111/F2-7, RTd111/F5-6, TJM-F92 and FJ1402 are inoculated with 30~35 age in days piglets respectively, through to pig body clinical symptoms, antibody test, Dissect lesion and pathological observation, the results showed that, rTd111/F5-6 virulence is similar to TJM-F92, hence it is evident that it is lower than FJ1402, And rTd111/F2-7 virulence is higher than rTd111/F5-6, illustrates that rTd111/F5-6 has the potentiality as vaccine candidate strain.It chooses 30-35 age in days sodium selenite further studies the piglet immunological Vaccine effectiveness of chimeric vaccine candidates rTd111/F5-6, is immunized 28d is utilized respectively HP-PRRSV strain BB0907 and class NADC30 strain FJ1402 and attacks poison, animal experiment knot through intramuscular injection afterwards Fruit shows that BB0907 and FJ1402 virus strain infection level is substantially reduced in rTd111/F5-6 immune group, and clinical symptoms and pathology become Change substantially reduced.Show that the chimeric strain has good immunogenicity, it can be to highly pathogenic strain and class NADC30 strain Infection provides effective Cross immunogenicity, has established important foundation for the disease new generation vaccine development.
Based on the above experimental result, the present invention selects rTd111/F5-6 to need the chimeric poison of PRRSV to be protected as the present invention Strain.In the rTd111/F5-6 the 5th generation for being fitted into strain, further cultivate and has carried out preservation, deposit number by the present invention For CGMCC No.14762, the entitled porcine reproductive and respiratory syndrome virus of preservation (porcine reproductive and Respiratory syndrome virus) rTd111/F5-6F5, depositary institution is Chinese microorganism strain preservation conservator Meeting common micro-organisms center (CGMCC), depositary institution address are Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, the deposit date is On May 25th, 2018.
Further, the porcine reproductive and respiratory syndrome virus (porcine reproductive and Respiratory syndrome virus) in rTd111/F5-6 F5 CGMCC No.14762 strain, the core of ORF5 and 6 Thuja acid is identical as the ORF5-6 of class NADC30 strain FJ1402, other open reading frames and highly pathogenic PRRSV TJM-F92 Vaccine low virulent strain is identical, but on Nsp2 gene 111 aa (323-433) of loss of expression segment.
Further, the porcine reproductive and respiratory syndrome virus (porcine reproductive and Respiratory syndrome virus) rTd111/F5-6 F5 CGMCC No.14762 strain nucleotide sequence such as SEQ Shown in ID NO.1, the nucleotide sequence of ORF5 is as shown in SEQ ID NO.2, the nucleotide sequence of ORF6 such as SEQ ID Shown in NO.3.
Further, the chimeric strain that the present invention constructs is to HP-PRRSV strain BB0907 and class NADC30 strain FJ1402 There is preferable immanoprotection action, therefore it also exists as the application of the candidate vaccine of porcine reproductive and respiratory syndrome prevalence strain Within the scope of the present invention, it is preferred that the PRRSV be fitted into strain be rTd111/F5-6 F5 CGMCC No.14762 or rTd111/F5-6。
Further, strain is fitted into the present invention also provides porcine reproductive and respiratory syndrome virus to breed and exhale in preparation pig Inhale the application in syndrome vaccine, it is preferred that it is rTd111/F5-6 F5 that the porcine reproductive and respiratory syndrome virus, which is fitted into strain, CGMCC No.14762 or rTd111/F5-6.
Further, the present invention also provides a kind of vaccine, which includes that the pig of immune amount breeds and exhales Syndrome virus chimeric strain is inhaled, which is rTd111/F5-6 F5 CGMCC No.14762 or rTd111/F5-6. Preferably, the immune amount of strain is fitted into vaccine are as follows: 105.0TCID50/ ml virus liquid.
Further, the present invention also provides above-mentioned vaccines in the drug of preparation prevention porcine reproductive and respiratory syndrome Using.Further, the porcine reproductive and respiratory syndrome be caused by classical porcine reproductive and respiratory syndrome virus strain infection, or It is to be caused by highly pathogenic PRRSV virus strain infection, or caused by PRRSV class NADC30 virus strain infection, or by above-mentioned three kinds Strain cross-infection causes.
The present invention is with highly pathogenic PRRSV TJM-F92 vaccine low virulent strain (i.e. high-pathogenicity porcine reproductive and respiration syndrome Strain TJM-F92 vaccine low virulent strain) full-length infectious CDNA clones and class NADC30 hypotype strain FJ1402 based on, utilize Reverse Genetics, building have obtained porcine reproductive and respiratory syndrome virus and have been fitted into strain.The chimeric strain experiment proves that, Viral growth speed and virus titer are lower than its original strain TJM-F92 on Marc-145 cell, and virulence is low, to HP-PRRSV poison Strain BB0907 and class NADC30 strain FJ1402 has preferable immanoprotection action, can be to highly pathogenic strain and class NADC30 virus strain infection provides effective Cross immunogenicity, and important foundation has been established in the development for the disease New-type wide-spectrum vaccine.
Preservation information
Porcine reproductive and respiratory syndrome virus rTd111/F5-6 F5 has been preserved in the micro- life of China on May 25th, 2018 Object culture presevation administration committee common micro-organisms center (CGMCC), depositary institution address are BeiChen West Road, Chaoyang District, BeiJing City 1 Number institute 3, deposit number are CGMCC No.14762.
Detailed description of the invention
Fig. 1 PRRSV is fitted into virus strain infection's property clone's building schematic diagram, and (A) lacks Nsp2 table using pCMV-TJM as skeleton Up to the segment of 111 aa, pTd111 is obtained, what is marked on the figure gene is the position of corresponding expression 323-433 amino acids; (B) constructs chimeric cDNA clone pTd111/F2-7 and pTd111/F5-6 using pTd111 as skeleton respectively.
Fig. 2 PRRSV is fitted into plaque form (A) and growth curve (B) of the strain on Marc-145 cell.
Fig. 3 PRRSV is fitted into lesion (A) and growth curve (B) of the strain on PAMs cell.
Fig. 4 virus infection PAMs Cellular inflammatory cell factor quantitative fluorescent PCR measurement result.
Piglet body temperature (A) and average daily gain (B) measurement result after Fig. 5 virus inoculation.
Fig. 6 PRRSV is fitted into after strain inoculation virus load (B) measurement knot in piglet viremia virusemia (A) and lung tissue Fruit.
14 days piglet lung tissue pathological observation results (200 ×) after Fig. 7 inoculation.
PRRSV detection of specific antibody result after Fig. 8 piglet immunological.
Fig. 9 HP-PRRSV BB0907 strain attacks piglet Temperature changing (A) and survivorship curve (B) after poison.
Figure 10 HP-PRRSV BB0907 strain attacks after poison virus in piglet viremia virusemia (A) and lungs and lymph node tissue Carrying capacity (B) measurement result.
Figure 11 HP-PRRSV BB0907 strain attacks piglet lungs naked eyes pathological change and changes in histopathology after poison.
Figure 12 PRRSV class NADC30 strain FJ1402 attacks piglet Temperature changing (A) and survivorship curve (B) after poison.
Figure 13 PRRSV class NADC30 strain FJ1402 is attacked after poison in piglet viremia virusemia (A) and lungs and lymph node tissue Virus load (B) measurement result.
Figure 14 PRRSV class NADC30 strain FJ1402 attacks piglet lungs naked eyes pathological change and histopathology change after poison Change.
Specific embodiment
The present invention is using high-pathogenicity porcine reproductive and respiration syndrome strain (abbreviation highly pathogenic PRRSV or HP-PRRSV) TJM-F92 vaccine low virulent strain infectious CDNA clones pCMV-TJM, (referred to as by porcine reproductive and respiratory syndrome class NADC30 strain Class NADC30 strain) Nsp2 gene expression characteristics, it is deleted on the Nsp2 gene of the vaccine strain and expresses 323-433 aa (totally 111 A aa) segment, construct infectious CDNA clones pTd111, then as skeleton, by its ORF2-7 (ORF2, ORF3, ORF4, ORF5, ORF6 and ORF7) and ORF5-6 (ORF5 and ORF6) replace with the corresponding of class NADC30 strain FJ1402 respectively ORFs (open reading frame), constructs infectious CDNA clones pTd111/F2-7 and pTd111/F5-6, and rescue is recombinated Viral rTd111 (TJM-F92 strain Nsp2 lacks 111 aa), (rTd111 strain ORF2-7 is set chimeric strain rTd111/F2-7 It is changed to FJ1402 strain ORF2-7) and rTd111/F5-6 (rTd111 strain ORF5-6 is replaced into FJ1402 strain ORF5-6), point In supplementary biography generation 5 times, gene inheritance is stablized.RTd111/F2-7 and rTd111/F5-6 is fitted into strain and grows on Marc-145 cell Speed and virus titer are lower than its original TJM-F92 strain, and the congenital immunity of infection PAMs cell rTd111/F5-6 induction is thin Intracellular cytokine expression is similar to its original vaccine strain TJM-F92, the congenital immunity cell factor of rTd111/F2-7 induction Expression is apparently higher than its original vaccine strain TJM-F92.By rTd111, rTd111/F2-7, rTd111/F5-6, TJM- F92 and FJ1402 is inoculated with 30~35 age in days piglets respectively, through to pig body clinical symptoms, antibody test, dissect lesion and pathology Learn observation, the results showed that, rTd111/F5-6 virulence is similar to TJM-F92, hence it is evident that lower than FJ1402, and rTd111/F2-7 virulence Higher than rTd111/F5-6.For the piglet immunological Vaccine effectiveness for further studying chimeric vaccine candidates rTd111/F5-6, choose 30-35 age in days sodium selenite, immune rear 28d are utilized respectively HP-PRRSV strain BB0907 and class NADC30 strain FJ1402 through flesh Poison is attacked in meat injection.Animal test results show that BB0907 and FJ1402 virus strain infection is horizontal obvious in rTd111/F5-6 experimental group It reduces.The above results show that the chimeric strain has good immunogenicity, can be to highly pathogenic strain and class NADC30 poison Strain infection provides effective Cross immunogenicity, has established important foundation for the disease new generation vaccine development.
In the following, enumerating the acquisition methods of the chimeric strain of the present invention, specifically so that those skilled in the art are more detailed to the present invention Thin understanding.In following methods, unless otherwise stated, Science and Technology noun used is logical with those skilled in the art The meaning understood.Also, infectious CDNA clones used herein, cell culture, cell transformation, virus transfection, virus The technologies such as rescue, immunological experiment, recombinant plasmid, recombinant virus are all the technologies that this field has had been reported that, step can be with It is carried out using conventional steps disclosed in the prior art.
Embodiment
1 material and method
1.1 viruses, cell and plasmid
PRRSV highly pathogenic strain BB0907 and class NADC30 strain FJ1402 is separated by this laboratory and is identified and protect It deposits, PRRSV vaccine (TJM-F92 plants) is given by force China, Hua Weite (Taizhou) bioengineering Co., Ltd, TJM-F92 vaccine strain Infectious CDNA clones plasmid pCMV-TJM, constructed and saved by this laboratory.The primary pulmonary alveolar macrophage of pig (PAMs) ginseng It is prepared according to literature method;Marc-145 cell is by this laboratory liquid nitrogen cryopreservation, and from the U.S., ATCC is purchased.
1.2 other reagents and test animal
RNA extracts kitTotal RNA Kit I is purchased from OMEGA;SuperScriptTMIII Reverse Transcriptase is purchased from Invitrogen;Restriction enzyme A scI and SpeI are purchased from NEB;DMEM/F12 training It supports base and is purchased from Vicente;Low melting point agar (Agarose) is purchased from SIGMA;IDEXX HerdChek PRRS X3ELISA kit purchase From IDEXX.30-35 age in days PRRSV, PCV2, PRV and CSFV antibody and antigen negative piglet cultivate purchased from Nantong City Family.
The building of 1.3 chimeric virus strain infection's property cDNA clones
1.3.1 design of primers
According to the gene order design primer of TJM-F92 strain and FJ1402 strain, primer sequence is shown in Table 1.Primer is by south The synthesis of Jing Jinsirui Bioisystech Co., Ltd, way of purification RPC.
1 infectious CDNA clones of table construct primer
In upper table, italic and the sequence underlined indicate restriction enzyme site, and the sequence of overstriking is the sequence of FJ1402 strain.
In upper table, each primer effect is as follows:
T-A-F and Td111aa-R is the primer for expanding TJM plants of A segment 111aa deletion segment leading portions;
Td111aa-F and T-A-R is the primer for expanding TJM plants of A segment 111aa deletion segment back segments;
T-A-F and T-A-R is by the primer of two sections of progress fusion DNA vaccines before and after TJM plants of A segment 111aa deletion segments;
T-D-F and T-1b-R is the primer for expanding TJM plants of D segment ORF2 leading portions;
FJ-2-F and FJ-7-R is the primer for expanding FJ1402 strain ORF2-ORF7;
T-3'UTR-F, T-D-SwaI and T-D-SpeI are the primers for expanding TJM plants of D segment ORF7 back segments;
T-D-F and T-4-R is the primer for expanding TJM plants of D segment ORF5 leading portions;
FJ-5-F and FJ-6-R is the primer for expanding FJ1402 strain ORF5-ORF6;
T-7-F, T-D-SwaI and T-D-SpeI are the primers for expanding TJM plants of D segment ORF6 back segments.
1.3.2 it is fitted into the building of virus strain infection's property cDNA clone plasmid
The specific steps of the TJM-F92 vaccine strain laboratory infectious CDNA clones pCMV-TJM PRRSV building are referring to text Offer " building and identification of the recombination porcine reproductive and respiratory syndrome virus of expression porcine circovirus 2 type ORF2 gene " (Zhang Tingjie Deng " viral journal " the 1st phase in 2015).
Using the PRRSV TJM-F92 vaccine strain infectious CDNA clones pCMV-TJM of laboratory building as skeleton, press PRRSV class NADC30 strain Nsp2 gene expression characteristics delete expression 323-433 altogether on the Nsp2 gene of pCMV-TJM The genetic fragment of 111 aa, building obtain infectious CDNA clones pTd111 (Fig. 1-A).Steps are as follows for specific experiment:
Using pCMV-TJM as template, TJM plants of A segments are expanded with T-A-F, Td111aa-R and Td111aa-F, T-A-R respectively 111aa deletion segment front and rear sections.It then, is primer with T-A-F and T-A-R using spread sheet section as template, it will by SOE PCR Forward and backward two sections are merged, and the A (d111) of missing 111aa is obtained.With PacI and XhoI respectively to segment A (d111) and pCMV- TJM carries out double digestion, to the segment and carrier progress recovery purifying after digestion and connects, finally by the A after missing 111aa (111aa) is successfully substituted into pCMV-TJM, obtains the pTd111 that Nsp2 has lacked 111aa.
PTd111 respective segments and the respective segments of FJ1402 strain are fused together by SOE PCR, are respectively obtained The recombination D segment (Td111/F2-7) of chimeric FJ1402 strain ORF2-7 and the recombination D segment of chimeric FJ1402 strain ORF5-6 (Td111/F5-6), the D segment being transformed is substituted into pTd111, the sense of access respectively eventually by double digestion (AscI and SpeI) Metachromia cDNA clone pTd111/F2-7 and pTd111/F5-6 (Fig. 1-B).Steps are as follows for specific experiment:
PTd111/F2-7 building: expanding ORF2 leading portion and ORF7 back segment in D segment using pTd111 as template respectively, with The cDNA of FJ1402 strain is template amplification ORF2-ORF7 sections, is fused together, is fitted by three sections by fusion DNA vaccine The D (Td111/F2-7) of FJ1402 strain ORF2-7;D (Td111/F2-7) and pTd111 are carried out with AscI and SpeI respectively double Digestion, by after digestion segment and carrier be attached, obtain pTd111/F2-7.
PTd111/F5-6 building: expanding ORF5 leading portion and ORF6 back segment in D segment using pTd111 as template respectively, with The cDNA of FJ1402 strain is template amplification ORF5-ORF6 sections, is fused together, is fitted by three sections by fusion DNA vaccine The D (Td111/F5-6) of FJ1402 strain ORF5-6;D (Td111/F5-6) and pTd111 are carried out with AscI and SpeI respectively double Digestion, by after digestion segment and carrier be attached, obtain pTd111/F5-6.
1.3.3 the identification and sequence for being fitted into virus strain infection's property cloned plasmids are analyzed
WithEndo-free Plasmid DNA Mini Kit I extracts infectious CDNA clones plasmid PTd111, pTd111/F2-7 and pTd111/F5-6, and chimeric place's nucleotide sequence is measured, it is analysed whether through BioEdit software In the presence of missing and mutation.
The rescue of 1.4 chimeric strains and biological property analysis
1.4.1 it is fitted into the rescue of strain
According to the method for 3000 specification of lipofectamine, respectively by infectious CDNA clones plasmid pTd111, Marc-145 cell of the pTd111/F2-7 and pTd111/F5-6 transfection in cell density up to 70~90%, be placed in 37 DEG C, 5%CO2Culture is observed in incubator.When hole, inner cell lesion CPE reaches 80% or so, harvest transfection cell, multigelation, Centrifugation takes the single layer Marc-145 cell continuous passage culture of vial supernatant access culture 48h.To being passaged to for the 5th generation (F5) Viral extraction RNA, send by template amplification ORF5 gene and Nsp2 gene of the cDNA after reverse transcription to Jin Sirui biotechnology Co., Ltd carries out sequence verification.Correct recombinant virus will be sequenced respectively and be named as rTd111, rTd111/F2-7 and rTd111/F5-6。
1.4.2 virus plaque experiment and growth curve measurement
Marc-145 cellular products multigelation 3 times for generating 80%CPE are collected, are diluted to 10 with DMEM-2To 10-4It is dilute Degree of releasing.It takes 100 holes μ l/ to be seeded to 12 orifice plates of confluent monolayers Marc-145 cell respectively, carries out plaque select according to a conventional method Test.Plaque to appear, picking plaque be connected to it is new cover in cell monolayer hole, purified virus 3~4 times, stabilization can be obtained With the recombinant virus of purifying.
By TJM-F92 vaccine strain and 3 kinds of chimeric strains of rescue respectively with the dose inoculation Marc-145 of MOI=0.1 Cell, 12h after infection, for 24 hours, 36h, 48h and 72h collect cell supernatant measurement TCID respectively50, according to different time points Virus titer draws viral one step growth curve (3 parallel holes are arranged in every kind of viral each time point).
Inducing action of the 1.5 chimeric strains to primary PAMs congenital immunity cell factor
To understand the variation that porcine alveolar macrophage PAMs infects generation major cytokine after chimeric strain, further explain The infection mechanism of bright chimeric strain.It chooses PRRSV, PCV2 and PRV antigen and antibody is negative common weanling pig, separation With culture PAMs, by each viral (TJM-F92, rTd111, rTd111/F2-7 and rTd111/F5-6) respectively with MOI=0.1's Dose inoculation cell (3 parallel holes are arranged in every kind of viral each time point), while setting does not connect malicious Mock control wells.In virus Different time points after inoculation (6h, 12h, for 24 hours, 36h, 48h and 72h) collect cell conditioned medium respectively, are detected with Real-time PCR Various cytokine mRNA levels and the titre for measuring virus draw viral one step growth curve.
Pathogenicity of the 1.6 chimeric strain vaccine Candidate Strains to piglet
30 PRRSV feminine gender piglets are divided into six groups (n=5) at random.1-5 group injects rTd111, rTd111/ respectively The virus liquid of F2-7, rTd111/F5-6, TJM-F92, FJ1402, injection volume are as follows: every pig muscle injection 3mL 105TCID50/ ML virus liquid, the interior observation piglet body temperature of the 6th group of injection isometric PBS, 14d and clinical symptoms.And 7d, 14d are adopted after immune Blood, serum is for measuring viremia virusemia.14d after immune, carries out all piglets to slaughter dissect, carries out general pathology change to lungs Change observation, takes lung tissue to freeze and measured for virus load;Separately part lung tissue is taken to be fixed with 4% paraformaldehyde and carries out disease Neo-Confucianism observation.
The immune protective of 1.7 chimeric strain vaccine Candidate Strains is tested
30 PRRSV feminine gender piglets are divided into 3 groups (n=10), isolated rearing at random.Wherein one group of every pig muscle note Penetrate 3mL TJM-F92 (105TCID50/ mL), another group of every pig muscle injection 3mL rTd111/F5-6 (105TCID50/ mL), Every pig muscle injection 3mL PBS of last group, observes the clinical symptoms of pig body daily.7d, 14d, 21d and 28d are adopted after immune Blood carries out Study On Immunogenicity.28d after immune, every group 5 use class using the highly pathogenic strain BB0907 attack of PRRSV, 5 NADC30 hypotype strain FJ1402 attack, 4mL/ head.After attacking poison, pig body state is observed daily, is measured rectal temperature, is being attacked respectively 7d, 14d and 21d blood sampling measurement viremia virusemia after poison.21d after poison is attacked, all piglets are carried out to slaughter dissect, lungs are carried out General pathology variation observation, takes lung tissue and tonsillotome to be used for the measurement and pathological study of virus load.
2 results
2.1 the Identification of Biological Characteristics of chimeric strain
As shown in Fig. 2, the plaque form and size of three kinds of recombinant viruses rTd111, rTd111/F2-7 and rTd111/F5-6 It is similar, with parent's strain TJM-F92 no significant difference.Growth curve the results show that rTd111 growth characteristics and parent's strain It is only variant in individual time point compared to almost the same.But strain rTd111/F2-7 and rTd111/F5-6 are fitted into Marc- Growth titre peak value in 145 cells is located at 48h after infection, is below parent's strain TJM-F92's and recombinant virus rTd111 Virus infection titer.
2.2 chimeric virus strain infection PAMs characteristics
There is obvious lesion after PAMs inoculation TJM-F92, rTd111, rTd111/F2-7 and rTd111/F5-6 strain, It is coarse to show as cell edges, there is the poly- heap (Fig. 3-A) in part.One step growth curve the results show that recombinant virus rTd111, RTd111/F2-7 and rTd111/F5-6 and parent plant TJM-F92 are also almost the same (Fig. 3-B) in the growth characteristics of PAMs cell.
Meet 6h, 12h after poison, for 24 hours, using fluorescent quantitation Real-time PCR method detection IL-6, TNF-α, IFN-β and The mRNA expression of IFN-γ, the results show that the inflammation inducing factor of recombinant strain rTd111 level with TJM-F92 strain without Notable difference (P > 0.05), and rTd111/F2-7 is the most significant (P < 0.05) to the up-regulation effect of inflammatory factor mRNA level in-site, RTd111/F5-6 to the induced levels of cell factor then between rTd111 and rTd111/F2-7 (Fig. 4).
Pathogenicity of the 2.3 embedded virus vaccine candidate strains to piglet
2.3.1 clinical change
Piglet is inoculated with 3ml (105TCID50/ml)rTd111、rTd111/F2-7、rTd111/F5-6、TJM-F92、FJ1402 After virus liquid, test group piglet does not occur obvious clinical abnormal symptom, and mean body temperature maintains between 39.5~40 DEG C or so. Further immune rear piglet 0d and 14d weight data is counted, as the result is shown embedded virus immune group and PBS group piglet Average daily gain also no significant difference (P > 0.05), see Fig. 5.
2.3.2 viremia virusemia and virus load measurement
PRRSV carrying capacity in serum is detected after each virus inoculation with fluorescence quantifying PCR method, as a result such as Fig. 6-A, rTd111/ F5-6, rTd111 (P > 0.05) similar with TJM-F92 immune group piglet PRRSV viremia, and rTd111/F2-7 is immune Group is slightly above viremia caused by above-mentioned three kinds of virus.Virus load testing result such as Fig. 6-B in lung tissue, Virus load and FJ1402 attack poison in each immune group piglet lungs of rTd111/F2-7, rTd111/F5-6, rTd111 and TJM-F92 Control group is compared and is substantially reduced (P < 0.05).
2.3.3 pathological study
14d slaughters all piglets after inoculation, acquires lung tissue, prepares histotomy, observes changes in histopathology, knot Fruit are as follows: rTd111/F5-6, rTd111 and TJM-F92 group only show slight lesion, and alveolar structure is complete, and alveolar septum slightly increases Thickness, and rTd111/F2-7 and FJ1402 group obviously show interstitial pneumonia lesion, inflammatory cells increased or red blood cell leaching Profit, alveolar wall thickening are more obvious (Fig. 7).Show that rTd111/F5-6 is pathogenic very low, and rTd111/F2-7 has certain cause a disease Property.
The immune protection effectiveness of 2.4 chimeric vaccine candidates
2.4.1 immune antibody assay
Swine serum is immunized to the different time points of acquisition and carries out antibody test with IDEXX PRRS X3ELISA kit.Knot Fruit shows the immune effect of chimeric strain rTd111/F5-6 and parent's vaccine strain TJM-F92 quite (p > 0.05), can be effective Excite the antibody mediated immunity response of piglet.PBS group piglet blood-serum P RRSV antibody is then always negative (S/P < 0.4) (Fig. 8).
2.4.2 HP-PRRSV BB0907 strain challenge test result
2.4.2.1 clinical symptoms
After HP-PRRSV BB0907 strain attacks poison, there is obvious fervescence (>=40 DEG C), duration in not immune piglet Relatively long, apathetic, loss of appetite, and it is dead 2 final.Chimeric strain rTd111/F5-6 and parent's vaccine strain TJM-F92 exempts from Piglet body temperature is without significantly raised and clinical symptoms after epidemic disease, all strong (Fig. 9) living.Evaluation result shows: chimeric strain rTd111/ F5-6 has good protective effect to the attack of PRRSV velogen strain BB0907.
2.4.2.2 viremia virusemia and tissue virus load
PRRSV carrying capacity after poison is attacked in fluorescence quantifying PCR method detection, as a result such as Figure 10-A, rTd111/F5-6 immune group and parent This vaccine strain TJM-F92 immune group piglet PRRSV viremia is close (P>0.05), be substantially less than non-immune group (P< 0.05)。
Virus load testing result such as Figure 10-B, rTd111/F5-6 immune group piglet lungs in lung tissue and lymph node And virus load is similar to parent's vaccine strain TJM-F92 (P>0.05) in lymph node, be substantially less than non-immunized controls group (P< 0.05), show the immune infection level that can reduce HP-PRRSV BB0907 strain of rTd111/F5-6.
2.4.2.3 lung pathology is observed
21d slaughters piglet after attacking poison, and Figure 11 is shown in lungs naked eyes pathological change, compared with non-Immunization control group, RTd111/F5-6 and TJM-F92 immune group piglet lungs are without obvious naked eyes lesion.Lung histology observation the results show that RTd111/F5-6 and TJM-F92 immune group alveolar structure is complete, and alveolar septum thickens unobvious.The above results show Piglet, which is immunized, in rTd111/F5-6 can be effectively reduced clinical symptoms and pathological change caused by HP-PRRSV BB0907 strain.
2.4.3 PRRSV class NADC30 strain FJ1402 challenge test result
2.4.3.1 clinical symptoms
After FJ1402 strain attacks poison, non-immune group piglet body temperature is significantly raised (>=40 DEG C), and dead 1, TJM-F92 is immune Generating heat (>=40 DEG C) also occurs in piglet, no phenomena of mortality, and piglet is immunized without obvious clinical symptoms (Figure 12), table in rTd111/F5-6 The immune attack that can be effective against class NADC30 strain FJ1402 of bright rTd111/F5-6.
2.4.3.2 viremia virusemia and tissue virus load
PRRSV carrying capacity after poison is attacked in fluorescence quantifying PCR method detection, as a result such as Figure 13-A, TJM-F92 immune group and is not immunized Group piglet PRRSV viremia is similar (P > 0.05), and rTd111/F5-6 immune group viremia virusemia is then substantially less than and is not immunized Group (P < 0.05).
Virus load testing result is shown in lung tissue and lymph node, and virus carries in TJM-F92 immune group piglet lungs Amount is not significant (P > 0.05) with non-Immunization control group difference, and rTd111/F5-6 immune group virus load is substantially less than not Immunized controls group (P < 0.05) (Figure 13-B) illustrates the immune infection level that can reduce FJ1402 strain of rTd111/F5-6, and The protecting effect of TJM-F92 vaccine strain is relatively poor.
2.4.3.3 lung pathology is observed
As shown in figure 14,21d slaughters piglet, TJM-F92 immune group and non-Immunization control group piglet lungs after attacking poison There is obvious enlargement, diffusivity and focal sample consolidation, lungs color are dark red.Histological examination shows interstitial pneumonia, alveolar Wall thickening, inflammatory cells increased or red blood cell infiltration.RTd111/F5-6 immune group piglet lungs are without obvious naked eyes lesion, tissue It learns and checks the slight lesion of performance, alveolar structure is complete, and alveolar septum slightly thickens.
The above results show that rTd111/F5-6 is immunized piglet and can be effectively reduced PRRSV class NADC30 strain FJ1402's Attack, and TJM-F92 cannot then provide the clinical protection effect to FJ1402 virus strain infection completely.
Sequence table
<110>Agricultural University Of Nanjing
<120>a kind of porcine reproductive and respiratory syndrome virus is fitted into strain and its application
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 14631
<212> DNA
<213>porcine reproductive and respiratory syndrome virus (porcine reproductive and respiratory syndrome virusrTd111/F5-6 F5 CGMCC No.14762)
<400> 1
atgacgtata ggtgttggct ctatgccacg gcatttgtat tgtcaggagc tgtgaccata 60
ggcacagccc aaaacttgct gcacgggaac accctcctgt gacagccctc ttcaggggga 120
ttaggggtct gtccctaaca ccttgcttcc ggagttgcac tgctttacgg tctctccacc 180
cctttaacca tgtctgggat acttgatcgg tgcacgtgta cccccaatgc cagggtgttt 240
gtggcggagg gccaggtcta ctgcacacga tgtctcagtg cacggtctct ccttcctctg 300
aatctccaag ttcctgagct tggggtgctg ggtctattct ataggcccga agagccactc 360
cggtggacgt tgccacgtgc attccccact gtcgagtgct cccccgccgg ggcctgctgg 420
ctttctgcga tctttccgat tgcacgaatg actagtggaa acctgaactt tcaacaaaga 480
atggtgcggg tcgcagctga aatctacaga gccggccaac tcacccctac agttctaaag 540
actctacaag tttatgaacg gggttgtcgc tggtacccca ttgtcgggcc cgtccctggg 600
gtgggcgttt acgccaactc cctgcatgtg agtgacaaac ctttcccggg agcaactcat 660
gtgttaacca acttgccgct cccgcagagg cccaaacctg aggacttttg cccttttgag 720
tgtgctatgg ctgacgtcta tgacattggt cgtggcgccg tcatgtatgt ggccggagga 780
aaggtctctt gggcccctcg tggtgggaat gaagtgaaat ttgaacctgt ccccaaggag 840
ttgaagttgg ttgcgaaccg actccacacc tccttcccgc cccatcacgt agtggacatg 900
tccaggttta ccttcatgac ccctgggagt ggtgtctcca tgcgggttga gtaccaatac 960
ggctgcctcc ccgctgacac tgtccctgaa ggaaactgct ggtggcgctt gtttgactcg 1020
ctcccaccgg aagttcagta caaagaaatt cgccacgcta accaatttgg ctatcaaacc 1080
aagcatggtg tccctggcaa gtacctacag cggaggctgc aagttaatgg tcttcggaca 1140
gtgaccgaca cacatggacc tatcgtcata cagtacttct ctgttaagga gagttggatc 1200
cgccacctga agttggtgga agaacccagc ctccccgggt ttgaggatct cctcagaatc 1260
agggttgagc ccaatacgtc accactggct ggaaaggatg agaagatttt ccggtttggc 1320
agtcataagt ggtacggtgc cggaaagaga gcaaggaaaa cacgctctgg tgcgactact 1380
atggtcgctc atcacgcttc gtccgctcat aaaatccggc aggccacgaa gcacgagggt 1440
gccggcgcta acaaggctga gcatctcaag cgctactctc cgcctgccga agggaactgt 1500
ggttggcact gcatttccgc catcgccaac cggatggtga attccaactt tgagaccacc 1560
cttcctgaaa gagtaaggcc ttcagatgac tgggccactg acgaggatct tgtgaatacc 1620
atccaaatcc tcaggctccc tgcggccttg gacaggaacg gcgcttgcgg tagcgccaag 1680
tacgtgctta aactggaggg tgagcattgg actgtctctg tgatccctgg gatgtcccct 1740
actttgctcc cccttgaatg tgttcagggt tgttgtgaac ataagggcgg tcttgtttcc 1800
ccggatgcgg tcgaaatttc cggatttgat cctgcctgcc ttgaccgact ggctaaggta 1860
atgcacttgc ctagcagtac catcccagcc gctctggccg aattgtccga cgactccaac 1920
cgtccggttt ccccggccgc tactacgtgg actgtttcgc aattctatgc tcgtcataga 1980
ggaggagatc atcatgacca ggtgtgctta gggaaaatca tcagcctttg tcaagttatt 2040
gaggactgct gctgccatca gaataaaacc aaccgggcta ctccggaaga ggtcgcggca 2100
aagattgatc agtacctccg tgacgcaaca agtcttgagg aatgcttggc caaacttgag 2160
agagtttccc cgccgagcgc agcggacacc tcctttgatt ggaatgttgt gcttcctggg 2220
gttgaggcga cgaatcagac aaccgaacaa cctcacgtca actcatgctg caccccggtc 2280
cctcccgtga ctcaagagcc tttgccaaga gttcaacctc gaagaacaaa gtctgtcaaa 2340
agtttgccag aggacaagcc tgtccctgct ccgcgcagga aggtcagatc cgattgcggc 2400
agcccggttt tgatgggcga caatgtccct aacggttcgg aagaaactgt cggtggtctc 2460
ctcaattttc cgacaccatc cgagccgatg acacctatga gtgagcccgt acttgtgccc 2520
gcgtcgcgac gtgtccccaa gctgatgaca cctttgagtg ggtcggcacc agttcctgca 2580
ccgcgtagaa ctgtgacaac aacgctgacg caccaggatg agcctctgga tttgtctgcg 2640
tcctcacaaa cggaatatga ggcttccccc ctaacaccat cgcagaacat gggcatcctg 2700
gaggcggggg ggcaagaagc tgagggagtc ctgagtgaaa tctcggatat actaaatgac 2760
accaaccctg cacctgtgtc atcaagcagc tccctgggtt cagtggccac cgaggatgtt 2820
ccacgcatcc tcgggaaaat aggagacact gacgagctgc ttgaccgagg tccctcggca 2880
ccctccaagg gagaaccggt ctgtgaccaa cctgccaaag atccccggat gtcgccgcgg 2940
gagtctgacg agagcataat agttccgccc gcagatacag gtggtgtcgg ctcattcact 3000
ggtttgccgt cttcagatgg tgtggatgtg gacggggggg ggccgttaag aacggtaaaa 3060
acaaaagcag aaaggctctt agatcaactg agctgccagg tttttagcct cgtttcccat 3120
ctccctattt tcttctcaca cctcttcaaa tctgacagtg gttattctcc gggtgattgg 3180
ggttttgcag cttttactct attttgcctc tttttatgtt acagttaccc attcttcggt 3240
tttgctcccc tcttgggtgt attttctggg tcttctcggc gtgtgcgaat gggggttttt 3300
ggctgctggt tggcttttgc tgttggtctg ttcaagcctg tgtccgaccc agtcggcact 3360
gcttgtgagt ttgactcgcc agagtgtagg aacgtccttc attcttttga gcttctcaaa 3420
ccttgggacc ctgtccgcag ccttgttgtg ggccccgtcg gtctcggcct tgccattctt 3480
ggcaggttac tgggcggggc acgctacatc tggcactttt tgcttaggct tggcattgtt 3540
gcagactgtg tcttggctgg agcttatgtg ctttctcaag gtaggtgtaa aaagtgctgg 3600
ggatcttgtg taagaactgc tcctaatgag atcgccttca acgtgttccc ttttacacgt 3660
gcgaccaggt cgtcactcat cgacctgtgc gatcggtttt gcgcaccaaa aggcatggac 3720
cccatttttc tcgccactgg gtggcgtggg tgctggaccg gccggagtcc cattgagcaa 3780
ccttctgaaa aacccatcgc gttcgcccag ctggatgaga agaggattac ggctagaact 3840
gtggtcgctc agccttatga tcccaaccag gccgtaaagt gcttgcgggt attacaggcg 3900
ggtggggcga tggtggccga ggcagtccca aaagtggtca aagtttccgc tattccattc 3960
cgagctcctt tctttcccgc tggagtgaaa gttgatcctg agtgcagaat cgtggttgat 4020
cccgatactt ttactacagc cctccggtct ggctattcca ccgcgaacct cgtccttggt 4080
acgggggact ttgcccagct gaatggacta aagatcaggc aaatttccaa gccttcaggg 4140
ggaggcccac acctcattgc tgccttgcat gttgcctgct cgatggcgtt acacatgctt 4200
gctggtgttt atgtaactgc agtggggtcc tgcggtgccg gtaccaacga tccgtggtgc 4260
actaacccgt ttgctgtccc tggctatgga cctggctctc tttgcacgtc tagattgtgc 4320
atctcccaac acggcctcac cttgcccttg acagcacttg tggcgggatt cggccttcaa 4380
gagattgcct tggtcgtttt gatctttgtc tccatcggag gcatggctca taggttgagt 4440
tgtaaggctg acatgttgtg catcttactc gcaatcgcta gttatgtttg ggtacctctt 4500
acctggttgc tttgtgtgtt tccttgttgg ttgcgctggt tctctttgca ccccctcacc 4560
atcctgtggt tggtgttttt cttgatttct gtaaatatac cctcgggaat cttggccgtg 4620
gtgttattgg tttctctctg gcttttaggt cgttatacta acattgctgg tctcgtcacc 4680
ccttatgaca ttcatcatta caccagtggc ccccgcggtg tcgccgcctt ggccaccgcg 4740
ccagatggaa cctacttggc tgccgtccgc cgtgctgcgc tgactggtcg taccatgctg 4800
ttcaccccgt ctcagcttgg gtccctcctt gagggcgctt tcagaactca aaaaccctca 4860
ctgaacaccg tcaatgtggt cgggtcctcc atgggctctg gcggagtgtt cactattgac 4920
gggaaaatca agtgcgtgac tgccgcacat gtccttacgg gtaactcagc tagggtttcc 4980
ggggtcggct tcaatcaaat gcttgacttt gatgtaaaag gggacttcgc catagctgat 5040
tgcccgaatt ggcaaggggt tgctcccaag gcccagttct gcgaggatgg gtggactggt 5100
cgcgcctatt ggctgacatc ctctggcgtt gaacccggtg ttattgggaa tgggttcgcc 5160
ttctgcttca ccgcgtgtgg cgattctgga tccccagtga ttaccgaagc cggtgagctt 5220
gtcggcgttc acacaggatc aaacaaacaa ggaggaggca ttgtcacgcg cccctcaggc 5280
cagttttgta atgtgaagcc catcaagctg agcgagttga gtgaattctt cgctggacct 5340
aaggtcccgc tcggtgatgt gaaaattggc agtcacataa ttaatgacac atgcgaggtg 5400
ccttcagatc tttgtgccct gcttgctgcc aaacccgaac tggaaggagg cctttccaca 5460
gttcaacttc tgtgtgtgtt tttcctcctg tggagaatga tggggcatgc ctggacgccc 5520
ttggttgctg tggggttttt catcctgaat gagattctcc cagctgttct ggtccggagt 5580
gttttctcct ttgggatgtt tgtgctatct tggctcacac catggtctgc gcaagtcctg 5640
atgatcaggc ttctgacagc agcccttaac agaaacagat ggtctcttgg tttttacagc 5700
cttggtgcaa taaccagttt tgtcgcagat cttgcggtaa ctcaagggca tccgttacag 5760
gtggtaatga acttaagcac ctatgccttc ctgccccgga tgatggttgt gacctcgcca 5820
gtcccagtga tcgcgtgtgg tgttgtgcac ctccttgcca taattttgta cttgtttaag 5880
taccgctgcc ttcacaatgt ccttgttggc gatggggtgt tctcttcggc tttcttcttg 5940
cgatactttg ccgagggaaa gttgagggaa ggggtgtcgc aatcctgtgg gatgagtcat 6000
gagtcgctga ctggtgccct cgccatgaga ctcactgacg aggacttgga tttccttacg 6060
aaatggactg attttaagtg ctttgtttct gcgtccaaca tgaggaatgc agcgggccaa 6120
tttatcgagg ctgcttatgc aaaagcacta agaattgaac ttgctcagtt ggtgcaggtt 6180
gataaggtcc gaggcaccat ggccaaactc gaggctttcg ccgataccgt ggcaccccaa 6240
ctctcgcccg gtgacattgt tgttgccctt ggccacacgc ctgttggcag catcttcgac 6300
ctaaaggttg gtagcaccaa gcatactctc caagctattg agactagagt ccttgccggg 6360
tccaaaatga ctgtggcgcg tgtcgttgac ccaacccccg cacccccgcc cgtacctgtg 6420
cccatccctc tcccaccgaa agttctggag aacggtccca atgcctgggg ggatgaggac 6480
cgtttgaaca agaagaagag gcgcaggatg gaagccgtcg gcatttttgt catggacggg 6540
aaaaagtacc agaaattttg ggacaagaat tccggtgatg tgttttatga ggaggtccat 6600
attagcacag acgagtggga gtgccttaga actggcgacc ctgtcgactt tgatcctgag 6660
acagggattc agtgtgggca tatcaccatt gaagataagg tttacaatgt cttcacctcc 6720
ccatctggta ggagattctt ggtccccgcc aaccccgaga atagaagagc tcagtgggaa 6780
gccgccaagc tttccgtgga gcaagccctt ggtatgatga acgtcgacgg cgaactgact 6840
gccaaagaac tggagaaact gaaaagaata attgacaaac tccagggcct gactaaggag 6900
cagtgtttaa actgctagcc gccagcggcc tgacccgctg tggtcgcggc ggcttagttg 6960
ttactgagac agcggtaaaa atagtcaaat ttcacaaccg gaccttcacc ctaggacctg 7020
tgaacttaaa agtggccagt gaggttgagc taaaagacgc ggttgagcac aaccaacatc 7080
cggttgccag accggttgat ggtggtgtcg tgctcctgcg ctctgcagtt ccttcgctta 7140
tagatgtctt gatctccggc gctgatacat ctcctaagtt actcgcccgc cacgggccgg 7200
gaaacactgg gattgatggc acgctttggg attttgaggc cgaggctact aaagaggaag 7260
ttgcactcag tgcgcaaata atacaggctt gtgatattag gcgcggcgac gcacctgaaa 7320
ttggtctccc ttataagttg taccctgtta ggggcaaccc tgagcgggta aaaggagttt 7380
tacagaacac aaggtttgga gacatacctt acaaaacccc cagtgacact ggaagcccgg 7440
tgcacgcggc tgcctgcctc acgcctaatg ctactccggt gactgatggg cgctccgtct 7500
tggctacaac catgccctct ggctttgagt tgtatgtgcc gaccattcca gcgtccgtcc 7560
ttgattatct tgattctagg cctgactgcc ctaaacagtt aacagagcac ggttgtgagg 7620
atgctgcatt aagagacctc tccaagtatg atttgtccac ccaaggcttt gttttgcctg 7680
gagttcttcg ccttgtgcgg aagtacctgt tcgcccacgt gggtaagtgc ccgcccgttc 7740
atcggccttc cacttaccct gctaagaatt ctatggctgg aataaatggg aacaggtttc 7800
caaccaagga cattcagagc gtccctgaaa tcgacgttct gtgcgcacag gctgtgcgag 7860
aaaactggca aactgttacc ccttgtaccc tcaagaaaca gtactgtggg aagaagaaga 7920
ctaggacaat acttggcacc aataacttca ttgcgttggc ccatcgggca gcgttgagtg 7980
gtgttaccca gggcttcatg aaaaaagcgt tcaactcgcc catcgccctc gggaaaaaca 8040
aatttaagga gctacaagcc ccggtcctag gcaggtgcct tgaagctgat cttgcgtcct 8100
gcgatcgatc cacacctgca attgtccgct ggtttgccgc caatcttctt tatgaactcg 8160
cctgtgctga ggagcatcta ccgtcgtacg tgctgaactg ctgccacgac ttactggtca 8220
cgcagtccgg cgcggtgact aagagaggtg gcctgtcgtc tggcgacccg attacctctg 8280
tgtcaaacac catttacagc ttagtgatat atgcacagca catggtgctc agttacttca 8340
aaagtgctca ccctcatggc cttctgtttc tgcaagacca gctgaagttt gaggacatgc 8400
tcaaggttca acccctgacc gtctattcgg acgaccttgt gctgtatgcc gagtctccct 8460
ccatgccaaa ctaccactgg tgggttgaac atctgaacct tatgctgggt ttccagacgg 8520
acccaaagaa gacaaccatc acagactcac catcattcct aggttgcagg ataataaatg 8580
ggcgccagct ggtccctaac cgtgacagga tcctcgcggc cctcgcctac cacatgaagg 8640
cgagcaatgt ttctgaatac tacgcctcgg cggctgcaat actcatggac agctgtgctt 8700
gtttggagta tgatcctgaa tggtttgaag agctcgtggt tgggatagcg cagtgcgccc 8760
gcaaggacgg ctacagcttt cctggcccac cgttcttctt gtccatgtgg gaaaaactca 8820
ggtccaatca tgaggggaag aagtccagaa tgtgcgggta ctgcggggcc ccggctccgt 8880
acgccactgc ctgtggtctc gatgtctgtg tttaccacac ccacttccac cagcattgtc 8940
ctgttataat ctggtgtggc cacccggcgg gttctggttc ttgtagtgag tgcgaacccc 9000
ccctaggaaa aggcacaagc cctctagatg aggtgttaga acaagttccg tacaagcctc 9060
cgcggactgt gatcatgcat gtggagcagg gtctcacccc tcttgaccca ggtagatacc 9120
agactcgccg cggattggtc tccgttaggc gtggcatcag gggaaatgaa gtcgacctac 9180
cagacggtga ttacgccagt accgccttgc tccctacttg taaagagatc aacatggtcg 9240
ctgtcgcctc taacgtgttg cgcagcaggt ttatcatcgg cccacccggt gctgggaaaa 9300
cacactggct tcttcaacaa gtccaggatg gtgatgtcat ttacacgcca actcaccaga 9360
ccatgctcga catgattagg gctttgggga cgtgccggtt caacgttcca gcaggtacaa 9420
cgctgcaatt ccctgccccc tcccgtaccg gcccatgggt tcgcatcttg gccggcggtt 9480
ggtgtcctgg caagaactcc ttcctggatg aagcggcgta ttgcaatcac cttgacgtct 9540
tgaggcttct cagtaaaaca actctcactt gcctagggga cttcaaacaa ctccaccctg 9600
tgggttttga ctcccattgc tatgtatttg acatcatgcc tcagacccaa ttaaagacca 9660
tctggaggtt cgggcagaat atctgtgatg ccattcaacc agattacagg gacaaactta 9720
tggccatggt caacacgacc cgtgtgacct acgtggaaaa acctgtcagg tacgggcaag 9780
tcctcacccc ctaccacagg gaccgagagg acggcgccat tactatcgac tccagtcaag 9840
gcgccacatt tgatgtggtt acactgcatt tgcccactaa agattcactc aacaggcaaa 9900
gagctcttgt tgctatcacc agggcaaggc atgctatctt cgtgtatgac ccacacaggc 9960
aattgcagag catgtttgat cttcccgcga gaggcacacc cgtcaacctc gcagtgcacc 10020
gtgacgaaca gctgatcgta ttagacagaa acaacagaga aatcacggtt gctcaggctc 10080
taggcaatgg agataaattc agggccacag ataagcgcgt tgtagattct ctccgcgcta 10140
tttgcgcaga cctggaaggg tcgagctccc cgctccccaa ggtcgcgcat aacttgggat 10200
tccatttctc acctgatttg actcagtttg ctaaactccc ggcagaactt gcaccccact 10260
ggcccgtggt gacaacccag aacaatgaaa ggtggccaga tcggctggta gccagcctcc 10320
gccctatcca taaatatagc cgcgcgtgca ttggtgccgg ctatatggtg ggcccctcgg 10380
tgtttttagg cacccctggg gttgtgtcat actatctcac aaaatttgtt agaggcgagg 10440
ctcaagtgct tccggagaca gtcttcagca ccggccgaat tgaggtagat tgtcgagagt 10500
atcttgatga tcgggagcga gaagttgctg agtccctccc acatgccttc atcggcgatg 10560
tcaaaggtac caccgttggg ggatgtcatc acgttacctc caaatacctt ccgcgcttcc 10620
ttcccaagga atcagttgcg gtggtcgggg tttcgagccc cgggaaagcc gcgaaagcag 10680
tttgcacatt gacggatgtg tacctcccag accttgaagc gtacctccac ccagagaccc 10740
agtccaggtg ctggaaagtg atgttggact ttaaggaggt tcgactgatg gtatggaaag 10800
acaagacggc ctattttcaa cttgaaggcc gccattttac ctggtatcaa cttgcaagct 10860
acgcctcata catccgagtt cctgttaatt ctactgtgta cttggacccc tgcatgggcc 10920
ctgctctttg caacaggagg gttgtcgggt ccacccattg gggagctgac ctcgcagtca 10980
ccccttatga ttacggtgcc aaaattattc tgtctagtgc ataccatggt gaaatgcctc 11040
caggttacaa aattctggcg tgcgcggagt tctcgcttga tgatccagta aggtacaaac 11100
acacctgggg atttgaatcg gatacagcgt atctgtacga gtttactgga aatggtgagg 11160
actgggagga ttacaatgat gcgtttcggg cgcgccagaa agggaaaatt tataaagcta 11220
atgccaccag catgaggttt cattttcccc cgggccctgt cattgaacca actttaggcc 11280
tgaattgaaa tgaaatgggg tctatgcaaa gcctctttga caaaattggc caactttttg 11340
tggatgcttt cacggaattt ctggtgtcca ttgttgatat catcatattt ttggccattt 11400
tgtttggctt cacaatcgcc ggttggctgg tggtcttatg catcagactg gtttgctccg 11460
cggtactccg tgcgcgctct accgttcacc ctgagcaatt acagaagatc ttatgaggcc 11520
tttctttctc agtgtcaggt agacattccc acctggggcg tcaaacaccc tttgggggtg 11580
ctttggcacc ataaggtgtc aaccctgatt gatgaaatgg tgtcgcgtcg aatgtaccgc 11640
gtcatggaaa aagcagggca ggctgcctgg aaacaggtgg tgagcgaggc tacattgtct 11700
cgcattagtg gtttggatgt ggtggctcat tttcaacatc ttgccgctat tgaagccgag 11760
acttgtaaat atttggcttc ccggctaccc atgctgcaca acctgcgctt gacagggtca 11820
aatgtaacca tagtgtataa tagtactttg gatcaggtgt ttgccatttt cccaacccct 11880
ggttcccggc caaagcttca tgattttcag caatggctaa tagctgtaca ttcctccata 11940
ttttcctccg ttgcagcttc ttgtactctt tttgttgtgc tgtggttgcg aattccaatg 12000
ctacgttctg tttttggttt ccgctggtta ggggcaactt ttcttttgaa ctcatggtga 12060
attacacggt atgcccgctt tgcccaaccc ggcaggcagc cgccgagatc cttgaacccg 12120
gcaagtcttt ttggtgcagg atagggcatg accgatgtag tgagaacgat catgacgaac 12180
tagggttcat ggttccgcct ggcctctcca gcgaaggcca cttgaccagt gtttacgcct 12240
ggttggcgtt cctgtccttc agctacacgg cccagttcca tcccgagata tttgggatag 12300
ggaatgtgag tcaagtttat gttgacatca agcaccaact catctgcgct gttcatgacg 12360
gggataacgc caccttgcct cgccatgaca atatttcagc cgtatttcag acctactacc 12420
aacaccaggt cgacggcggc aattggtttc acctggaatg gctacgccct ttcttttcct 12480
cttggttggt tttaaatgtt tcgtggtttc tcaggcgttc gcctgcaagc catgtttcag 12540
ttcgagtctt tcggacatca aaaccaacac caccgcagca tcaggcttcg ttgtcctcca 12600
ggacatcagc tgccttaggc atggcgactc gtcctctccg acgattcgca aaagttctca 12660
gtgccgcacg gcgataggga cgcccgtgta catcaccatc actgccaatg tcacagatga 12720
aaattatcta cattcttctg atctcctcat gctttcttct tgccttttct atgcttccga 12780
gatgagtgaa aagggattca aagtggtgtt tggcaatgtg tcaggcatcg tggctgtgtg 12840
cgtcaacttt accagctacg tccaacacgt caaggagttt acccaacgct ccttagtggt 12900
cgatcatgtg cgactgcttc atttcatgac acctgagacc atgaggtggg caaccgtttt 12960
agcctgtctt tttgccatcc tactggcaat ttgaatgttc aagtatgttg gggaaatgct 13020
tgaccgcggg ttactactcg caattgcctt ttttgtggta tatcgtgcca ttctgttttg 13080
ctgcgctcgt caacgccagc agcaacagca gctcccattt acagttgatt tataacctga 13140
cgatatgtga gctgaatggc acagattggc tgagcacaaa atttgactgg gcagtggaga 13200
ctttcgttat ctttcctgtg ttgactcata ttgtctctta cggcgccctt accactagcc 13260
attttcttga cacggtcggc ctgatcactg tgtccaccgc cggttattat cacaagcggt 13320
atgtattgag tagcatctac gctgtctgtg ccctggctgc gttggtttgc ttcgccatta 13380
ggttggcgaa aaattgcatg tcctggcgct actcatgcac cagatatacc aattttcttc 13440
tggatactaa gggcaaactc taccgctggc ggtcacccgt catcattgag aaggggggta 13500
aagttgatgt tgaaggtcat ttaatcgacc tcaagacagt tgtgcttgat ggttccgcgg 13560
caacccctgt aaccaagatt tcagcggaac aatggggtcg tccatagacg acttctgcaa 13620
tgacagcacg gctgtacaaa aggtgctctt ggcgttttct atcacctaca cgccaataat 13680
gatatatgcc ttaaaagtaa gtcgtggtcg actgctgggg cttttacacc tcttgatttt 13740
cctgaactgt gctttcactt ttgggtatat gacatttgtc cattttcaga gtacaaacaa 13800
ggtcgcactt accctggggg cagttgtcgc tctcctctgg ggggtgtatt cagccctgga 13860
aacctggaga ttcatcacct ccaggtgccg gttgtgcttg ctaggccgca agtacattct 13920
ggcccctgcc caccacgtag aaagtgccgc aggctttcat ccgataacgg caagtgataa 13980
ccacgcattt gtcgtccggc gtcccggctc cactacggtc aacggcacac tggtgcccgg 14040
gttgaaaagc ctcgtgttgg gtggcagaag agctgtcaaa cgaggagtgg tgaaccttgt 14100
taaatatgcc aaataacaac ggcaagcagc aaaagaaaaa gaaggggaat ggccagccag 14160
tcaatcagct gtgccaaatg ctgggtaaga tcatcgccca acaaaaccag tccagaggca 14220
agggaccggg gaagaaaaat aggaagaaaa acccggggaa gccccatttc cctctagcga 14280
ctgaagatga cgtcaggcat cactttaccc ctagtgagcg gcaattgtgt ctgtcgtcga 14340
tccagactgc cttcaatcag ggtgctggaa cttgtgccct gtcagattca gggaggataa 14400
gttacactgt ggagtttagt ttgccgacgc aacatactgt gcgtctgatc cgcgccacag 14460
catcaccctc agcatgatgg gctggcattc tttggcacct cagtgttaga attgggagaa 14520
tgtgtggtga atggcactga ttgacactgt gcctctaagt cacctattca attagggcga 14580
ccgtgtgggg gtaaagttta attggcgaga accatgcggc cgtaattaaa a 14631
<210> 2
<211> 603
<212> DNA
<213>porcine reproductive and respiratory syndrome virus (porcine reproductive and respiratory syndrome virusrTd111/F5-6 F5 CGMCC No.14762)
<400> 2
atgttgggga aatgcttgac cgcgggttac tactcgcaat tgcctttttt gtggtatatc 60
gtgccattct gttttgctgc gctcgtcaac gccagcagca acagcagctc ccatttacag 120
ttgatttata acctgacgat atgtgagctg aatggcacag attggctgag cacaaaattt 180
gactgggcag tggagacttt cgttatcttt cctgtgttga ctcatattgt ctcttacggc 240
gcccttacca ctagccattt tcttgacacg gtcggcctga tcactgtgtc caccgccggt 300
tattatcaca agcggtatgt attgagtagc atctacgctg tctgtgccct ggctgcgttg 360
gtttgcttcg ccattaggtt ggcgaaaaat tgcatgtcct ggcgctactc atgcaccaga 420
tataccaatt ttcttctgga tactaagggc aaactctacc gctggcggtc acccgtcatc 480
attgagaagg ggggtaaagt tgatgttgaa ggtcatttaa tcgacctcaa gacagttgtg 540
cttgatggtt ccgcggcaac ccctgtaacc aagatttcag cggaacaatg gggtcgtcca 600
tag 603
<210> 3
<211> 525
<212> DNA
<213>porcine reproductive and respiratory syndrome virus (porcine reproductive and respiratory syndrome virusrTd111/F5-6 F5 CGMCC No.14762)
<400> 3
atggggtcgt ccatagacga cttctgcaat gacagcacgg ctgtacaaaa ggtgctcttg 60
gcgttttcta tcacctacac gccaataatg atatatgcct taaaagtaag tcgtggtcga 120
ctgctggggc ttttacacct cttgattttc ctgaactgtg ctttcacttt tgggtatatg 180
acatttgtcc attttcagag tacaaacaag gtcgcactta ccctgggggc agttgtcgct 240
ctcctctggg gggtgtattc agccctggaa acctggagat tcatcacctc caggtgccgg 300
ttgtgcttgc taggccgcaa gtacattctg gcccctgccc accacgtaga aagtgccgca 360
ggctttcatc cgataacggc aagtgataac cacgcatttg tcgtccggcg tcccggctcc 420
actacggtca acggcacact ggtgcccggg ttgaaaagcc tcgtgttggg tggcagaaga 480
gctgtcaaac gaggagtggt gaaccttgtt aaatatgcca aataa 525

Claims (10)

1. a kind of porcine reproductive and respiratory syndrome virus is fitted into strain, it is characterized in that: the porcine reproductive and respiratory syndrome virus Chimeric strain is the expression 323-433 on the Nsp2 gene by highly pathogenic PRRSV vaccine strain The genetic fragment of amino acids deletes while the ORF5-6 of the strain being replaced with to the ORF5-6 structure of PRRSV class NADC30 strain Obtained by building.
2. porcine reproductive and respiratory syndrome virus according to claim 1 is fitted into strain, it is characterized in that: described highly pathogenic Porcine reproductive and respiratory syndrome virus vaccine strain is highly pathogenic PRRSV TJM-F92 vaccine low virulent strain, the PRRSV class NADC30 strain is class NADC30 strain FJ1402.
3. a kind of porcine reproductive and respiratory syndrome virus is fitted into strain, it is characterized in that: entitled porcine reproductive and respiratory syndrome is sick Malicious rTd111/F5-6 F5, deposit number are CGMCC No.14762.
4. porcine reproductive and respiratory syndrome virus according to claim 3 is fitted into strain, it is characterized in that: its nucleotide sequence As shown in SEQ ID NO.1.
5. porcine reproductive and respiratory syndrome virus described in claim 1 or 3 is fitted into the construction method of strain, it is characterized in that including Following steps:
(1) infectious CDNA for constructing highly pathogenic PRRSV TJM-F92 vaccine low virulent strain clones pCMV-TJM;
(2) segment that 323-433 amino acids are expressed on the Nsp2 gene of pCMV-TJM is deleted, building obtains infectivity CDNA clone pTd111;
(3) using pTd111 as skeleton, its ORF5 and ORF6 are replaced with into porcine reproductive and respiratory syndrome class NADC30 strain The ORF5 and ORF6 of FJ1402, building obtain infectious CDNA clones pTd111/F5-6;
(4) pTd111/F5-6 is subjected to virus rescue, obtains porcine reproductive and respiratory syndrome virus rTd111/F5-6, is i.e. pig is numerous It grows and respiratory syndrome virus chimeric strain.
It breeds and breathes 6. porcine reproductive and respiratory syndrome virus of any of claims 1-5 is fitted into strain as pig The application of the candidate vaccine of syndrome prevalence strain.
It breeds and exhales in preparation pig 7. porcine reproductive and respiratory syndrome virus of any of claims 1-5 is fitted into strain Inhale the application in syndrome vaccine.
8. a kind of vaccine, it is characterized in that: effective component include immune amount pig of any of claims 1-5 breeding with Respiratory syndrome virus chimeric strain.
9. application of the vaccine according to any one of claims 8 in the drug of preparation prevention porcine reproductive and respiratory syndrome.
10. application according to claim 9, it is characterized in that: the porcine reproductive and respiratory syndrome is bred by classical pig Virus strain infection causes with respiration syndrome, or is caused by high-pathogenicity porcine reproductive and respiration syndrome virus strain infection, or by Porcine reproductive and respiratory syndrome class NADC30 virus strain infection causes, or is caused by above-mentioned three kinds of strain cross-infections.
CN201910046125.0A 2019-01-18 2019-01-18 Porcine reproductive and respiratory syndrome virus chimeric strain and application thereof Active CN109762792B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910046125.0A CN109762792B (en) 2019-01-18 2019-01-18 Porcine reproductive and respiratory syndrome virus chimeric strain and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910046125.0A CN109762792B (en) 2019-01-18 2019-01-18 Porcine reproductive and respiratory syndrome virus chimeric strain and application thereof

Publications (2)

Publication Number Publication Date
CN109762792A true CN109762792A (en) 2019-05-17
CN109762792B CN109762792B (en) 2022-03-25

Family

ID=66452474

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910046125.0A Active CN109762792B (en) 2019-01-18 2019-01-18 Porcine reproductive and respiratory syndrome virus chimeric strain and application thereof

Country Status (1)

Country Link
CN (1) CN109762792B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110904055A (en) * 2019-11-15 2020-03-24 华南农业大学 Porcine reproductive and respiratory syndrome virus recombinant vaccine strain PRRSV-SP and preparation method and application thereof
CN111676247A (en) * 2020-06-30 2020-09-18 扬州大学 Infectious clone construction, rescue and application of porcine reproductive and respiratory syndrome virus type 1 isolate
CN111849924A (en) * 2020-06-23 2020-10-30 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) Similar NADC30 porcine reproductive and respiratory syndrome virulent strain, attenuated strain and application thereof
CN113046329A (en) * 2020-11-10 2021-06-29 山东省滨州畜牧兽医研究院 Porcine reproductive and respiratory syndrome virus chimeric recombinant PRRSV DIVA vaccine strain cDY56
CN113151195A (en) * 2020-12-10 2021-07-23 武汉科前生物股份有限公司 Porcine reproductive and respiratory syndrome chimeric recombinant vaccine strain and application thereof
CN114134179A (en) * 2021-12-13 2022-03-04 扬州大学 Porcine reproductive and respiratory syndrome chimeric virus expressing porcine epidemic diarrhea virus G2 type S/S1 and application thereof
CN114717361A (en) * 2022-04-08 2022-07-08 漳州傲农现代农业开发有限公司 Fluorescent probe primer and kit for porcine reproductive and respiratory syndrome (NADP) NADC30 strain and application of fluorescent probe primer and kit
CN116036253A (en) * 2022-11-24 2023-05-02 畜科生物工程有限公司 Live vaccine for porcine reproductive and respiratory syndrome and preparation method thereof
WO2024029707A1 (en) * 2022-08-02 2024-02-08 을지대학교 산학협력단 Chimeric strain of north american and european porcine reproductive and respiratory syndrome virus, and method for producing same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107537031A (en) * 2016-06-27 2018-01-05 普莱柯生物工程股份有限公司 A kind of vaccine combination for preventing porcine reproductive and respiratory syndrome and its preparation method and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107537031A (en) * 2016-06-27 2018-01-05 普莱柯生物工程股份有限公司 A kind of vaccine combination for preventing porcine reproductive and respiratory syndrome and its preparation method and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
QIAOYA ZHANG ET AL.: "Pathogenicity and antigenicity of a novel NADC30-like strain of porcine reproductive and respiratory syndrome virus emerged in China", 《VETERINARY MICROBIOLOGY》 *
卞婷等: "猪繁殖与呼吸综合征病毒类NADC30株CHsx1401感染性克隆的构建", 《畜牧兽医学报》 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110904055A (en) * 2019-11-15 2020-03-24 华南农业大学 Porcine reproductive and respiratory syndrome virus recombinant vaccine strain PRRSV-SP and preparation method and application thereof
CN110904055B (en) * 2019-11-15 2023-10-13 华南农业大学 PRRSV-SP (porcine reproductive and respiratory syndrome virus) recombinant vaccine strain, and preparation method and application thereof
CN111849924B (en) * 2020-06-23 2022-05-10 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) Similar NADC30 porcine reproductive and respiratory syndrome virulent strain, attenuated strain and application thereof
CN111849924A (en) * 2020-06-23 2020-10-30 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) Similar NADC30 porcine reproductive and respiratory syndrome virulent strain, attenuated strain and application thereof
CN111676247A (en) * 2020-06-30 2020-09-18 扬州大学 Infectious clone construction, rescue and application of porcine reproductive and respiratory syndrome virus type 1 isolate
CN113046329A (en) * 2020-11-10 2021-06-29 山东省滨州畜牧兽医研究院 Porcine reproductive and respiratory syndrome virus chimeric recombinant PRRSV DIVA vaccine strain cDY56
CN113046329B (en) * 2020-11-10 2024-01-30 山东省滨州畜牧兽医研究院 Porcine reproductive and respiratory syndrome virus chimeric recombinant PRRSV DIVA vaccine strain cDY56
CN113151195B (en) * 2020-12-10 2022-07-12 武汉科前生物股份有限公司 Porcine reproductive and respiratory syndrome chimeric recombinant vaccine strain and application thereof
CN113151195A (en) * 2020-12-10 2021-07-23 武汉科前生物股份有限公司 Porcine reproductive and respiratory syndrome chimeric recombinant vaccine strain and application thereof
CN114134179A (en) * 2021-12-13 2022-03-04 扬州大学 Porcine reproductive and respiratory syndrome chimeric virus expressing porcine epidemic diarrhea virus G2 type S/S1 and application thereof
CN114134179B (en) * 2021-12-13 2023-09-01 扬州大学 Porcine reproductive and respiratory syndrome chimeric virus expressing G2 type porcine epidemic diarrhea virus S/S1 and application thereof
CN114717361A (en) * 2022-04-08 2022-07-08 漳州傲农现代农业开发有限公司 Fluorescent probe primer and kit for porcine reproductive and respiratory syndrome (NADP) NADC30 strain and application of fluorescent probe primer and kit
WO2024029707A1 (en) * 2022-08-02 2024-02-08 을지대학교 산학협력단 Chimeric strain of north american and european porcine reproductive and respiratory syndrome virus, and method for producing same
CN116036253A (en) * 2022-11-24 2023-05-02 畜科生物工程有限公司 Live vaccine for porcine reproductive and respiratory syndrome and preparation method thereof
CN116036253B (en) * 2022-11-24 2023-12-26 畜科生物工程有限公司 Live vaccine for porcine reproductive and respiratory syndrome and preparation method thereof

Also Published As

Publication number Publication date
CN109762792B (en) 2022-03-25

Similar Documents

Publication Publication Date Title
CN109762792A (en) A kind of porcine reproductive and respiratory syndrome virus is fitted into strain and its application
CN111218459A (en) Recombinant novel coronavirus vaccine taking human replication-defective adenovirus as vector
CN110551695A (en) African swine fever virus four-gene deletion low virulent strain and application thereof
US10918710B2 (en) Temperature-sensitive attenuated FMDV strains, construction method and application thereof
CN110759973B (en) Cell strain for expressing African swine fever virus CD2v protein and application thereof
US9315781B2 (en) Infectious CDNA clone of european PRRS virus and uses thereof
CN109195623A (en) 2 type of chimeric porcine circovirus type (PCV2) vaccine
CN105829528A (en) Prrs virus variant, european prrs virus cdna clone, and uses thereof
CN108473539A (en) Feline calicivirus vaccine
CN103266091A (en) A type foot-and-mouth disease recombinant vaccine strains and preparation method and application thereof
CN110628817A (en) Construction method and application of recombinant porcine reproductive and respiratory syndrome virus for expressing African swine fever virus p30 protein
WO2020258757A1 (en) Mutant strain of type 3 duck hepatovirus ch-p60-117c strain and construction method therefor
CN110904153A (en) Construction method and application of recombinant porcine reproductive and respiratory syndrome virus for expressing African swine fever virus p12 or p17 protein
CN103555680B (en) One has immunogenic PRRSV virus-like particle and preparation and application thereof
CN114854698B (en) O-type foot-and-mouth disease virus strain with improved replication titer, construction method and application thereof
CN104561092B (en) Express construction method and the application of CSFV E 2 protein recombination PRRS viral genetic engineering vaccine
CN101205539B (en) Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines
Liu et al. Altered pathogenicity, immunogenicity, tissue tropism and 3′-7 kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos
CN103773740B (en) Pig breathes the structure with reproductive syndrome virus replication defective virus vaccine strain and application
CN111996201B (en) Samlika recombinant virus and recombinant vaccine strain of recombinant A-type foot-and-mouth disease virus VP1 gene, and preparation method and application thereof
Dai et al. Research progress in the development of porcine reproductive and respiratory syndrome virus as a viral vector for foreign gene expression and delivery
CN105802921B (en) Recombinant pseudorabies virus variant strain for expressing classical swine fever virus E2protein and construction method and application thereof
CN109536464B (en) Chikungunya virus infectious clone with deletion of capsid protein gene, construction method and application in preparation of attenuated vaccine
CN112831477A (en) Recombinant pseudorabies virus strain expressing classical swine fever virus E2 protein and porcine circovirus Cap protein as well as construction method and application thereof
CN112375746B (en) Coxsackie group A type 2 virus mutant strain and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant